.. $235 million announced for growth of biotech sector at CSL By Dr Ananya Mandal, MD A $235 million growth of Australia’s largest biotech service in Melbourne is planned and this is likely to create hundreds of jobs. CSL biopharmaceutical research complicated in Broadmeadows, in the north of Melbourne will be receiving this school funding from both State in addition to Federal government over a five year investment plan. This will generate an estimated 320 temporary construction jobs and 333 new highly-skilled medical research openings by 2018 later. Related StoriesSausages With Antioxidants From Berries To Prevent CancerMD Anderson research reveals why chemotherapy drugs not effective for most pancreatic cancer patientsNew results reveal association between colorectal cancers and melanoma drug treatmentAt present CSL targets vaccine development but with the new funds more avenues of research like in cancer, blood related diseases, inflammation and infections in addition to drug development and medical trials, are expected to open up.Coloplast develops services and products for those who have personal and private medical conditions. These conditions are treated well in the western world, but in developing countries, like India, they get any attention hardly. The knowledge level is low, and the results for these people are large, says Per Ole Nielsen, Senior Project Manager, Access to Healthcare, Coloplast. SOURCE Usage of Healthcare.
Charlotte J. Haug, M.D., Ph.D.1 The retractions came only a few months after BioMed Central, an open-access publisher owned by Springer, retracted 43 content articles for the same reason. How is it possible to fake peer review? Moon, who studies medicinal vegetation, had set up a simple treatment. He gave journals recommendations for peer reviewers for his manuscripts, offering them with e-mail and titles addresses.